Unannounced audits could spell end for PVC-based plastics in medical devices in EU
This article was originally published in SRA
Executive Summary
EU manufacturers may wish to consider phasing out the use of PVC in the manufacture of their medical devices, or risk exorbitant costs linked to unannounced audits by notified bodies of suppliers in far-flung places. This is the view of Andy Vaughan, an Association of British Healthcare Industries' consultant responsible for standards policy work.